Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 7,517 | 577 | 657 | 1,109 | 626 |
| Cost of Goods | 210 | 320 | 350 | 620 | 330 |
| Gross Profit | 7,330 | 250 | 290 | 480 | 320 |
| Operating Expenses | 3,750 | 2,580 | 3,910 | 3,120 | 3,010 |
| Operating Income | 3,767 | -2,003 | -3,253 | -2,011 | -2,384 |
| Interest Expense | 20 | 20 | 10 | 10 | 30 |
| Other Income | 33 | -17 | -467 | -119 | 324 |
| Pre-tax Income | 3,780 | -2,040 | -3,730 | -2,140 | -2,090 |
| Net Income Continuous | 3,783 | -2,040 | -3,739 | -2,143 | -2,100 |
| Net Income | $3,783 | $-2,040 | $-3,739 | $-2,143 | $-2,100 |
| EPS Basic Total Ops | 79.23 | -43.22 | -79.23 | -45.62 | -45.62 |
| EPS Basic Continuous Ops | 79.98 | -43.22 | -79.22 | -45.79 | -45.65 |
| EPS Diluted Total Ops | 79.23 | -43.22 | -79.23 | -45.62 | -45.62 |
| EPS Diluted Continuous Ops | 79.98 | -43.22 | -79.22 | -45.79 | -45.65 |
| EBITDA(a) | $3,727 | $-1,623 | $-3,393 | $-1,901 | $-2,264 |